Digital Biomarkers Market Revenue to cross US$ 35.8 billion by 2035

Published: April 2024


According to a recently published report by Roots Analysis, the growing demand for remote patient monitoring solutions and ongoing technological advancements are driving the digital biomarkers market.

Digital Biomarkers Industry Overview

The global digital biomarkers market is anticipated to grow at a CAGR of  CAGR of 18.5%, reaching at USD 35.8 billion by 2035, during the forecast period 2024-2035.

The digitalization of the healthcare industry has facilitated access to care, streamlined the workflows and enhanced patient outcomes. Digital biomarkers are objective, measurable characteristics (behavioral, cognitive, idiosyncratic, physiological and vocal) that are collected via portable, wearable, ingestible or implantable devices to predict health-related information. It is worth highlighting that the COVID-19 pandemic has accentuated the demand for safe and efficacious remote patient monitoring solutions. Further, integration of machine learning algorithms and artificial intelligence in this domain enables analysis of large-scale biomarker data and unravelling patterns that were earlier undetectable.

Browse 130+ figures and 195+ market data tables spread across 365+ pages and detailed Table of Content on “Digital Biomarkers Market: Industry Trends and Global Forecasts, till 2035, by Type of Product (Software / Applications, Wearables, and Others), Purpose of Solution (Diagnosis, Early Detection, Monitoring and Predictive Insights), Type of Biomarker (Behavioral, Cognitive, Idiosyncratic, Physiological, Vocal and Others), Therapeutic Area (Autoimmune Disorders, Cardiovascular Disorders, Infectious Disorders, Mental Health Disorders, Neurological Disorders, Respiratory Disorders and Others), Business Model (B2B and B2C), and Key Geographical Regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the World)” here: https://www.rootsanalysis.com/reports/digital-biomarkers-market.html

Market Drivers

Given the growing demand for digital health monitoring solutions, the market for digital biomarkers is anticipated to grow remarkably over the coming years. Notably, the increasing adoption of smart wearable devices (allowing real-time monitoring of physiological parameters) is an important factor driving the growth in this domain. Further, the rising number of decentralized clinical trials is likely to elevate the demand for digital biomarkers in the coming years, enabling participants to engage from their homes rather than traditional clinical settings. The surging burden of neurodegenerative disorders is also anticipated to expand the market potential as digital biomarkers are extensively being used to treat and manage such disorders.

Market Restraints

While the digital biomarkers market is experiencing substantial growth, there are certain restraints that can potentially hinder the growth of the industry. One of the major factors is the concerns related to privacy and security of sensitive health information. Further, the process of discovering, developing and validating digital biomarkers require high capital investments, thereby adding high cost burden on stakeholders. Since digital biomarkers rely on data generation from diverse sources, such as wearable devices, mobile applications and online software, achieving seamless integration among these systems also poses a technical challenge.

Growth Factors

Despite the aforementioned challenges, various growth factors continue to drive the digital biomarkers market forward. One of the primary factors includes the ongoing technological advancements (including artificial intelligence and machine learning based algorithms) that enhance efficiency and credibility and allow development of novel digital biomarkers. In addition, the rising prevalence of chronic disorders is anticipated to fuel the demand for digital biomarkers, due to the various advantages offered by these solutions, such as early detection of disorders, remote monitoring, risk assessment and preventive care of the patients.

Digital Biomarkers Market Segments

Based on the type of product, the market is segmented into Software / Applications, Wearables Sensors and Gaming Solutions.

  • The wearables segment captures the largest revenue share of close to 50% in the digital biomarkers market, in 2024.
  • The sensors segment is anticipated to be the fastest growing segment in this industry, with annualized  rate (CAGR) of over 19.5% during the forecast period.

Based on the purpose of solution, the market is segmented into Diagnosis Digital Biomarkers, Early Screening Digital Biomarkers, Monitoring Digital Biomarkers and Predictive Insights Digital Biomarkers.

  • The digital biomarkers for monitoring capture the largest revenue share of around 40% in the digital biomarkers market, in 2024.
  • The digital biomarkers market for predictive insights is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 20.3% during the forecast period.

Based on the type of biomarker, the market is segmented into Cognitive, Idiosyncratic, Physiological, Vocal and Other Biomarkers.

  • The physiological digital biomarkers segment captures the largest revenue share of around 55% in the digital biomarkers market, in 2024.
  • The vocal biomarkers segment of the digital biomarkers market is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of around 21% during the forecast period.

Based on the therapeutic area, the market is segmented into Autoimmune Disorders, Cardiovascular Disorders, Infectious Disorder, Mental Health Disorders, Neurological Disorders, Respiratory Disorders, Substance Abuse Disorders and Other Disorders

  • Neurological disorders capture the largest revenue share of around 30% in in the digital biomarkers market, in 2024.
  • The digital biomarkers market for autoimmune disorders and substance abuse disorders are anticipated to be the fastest growing segments in this industry, with annualized rate (CAGR) of 20.8%, during the forecast period.

Based on the type of business model, the market is segmented into B2B and B2C

  • The B2C segment captures the largest revenue share of over 60% in the digital biomarkers market, in 2024.
  • The B2B segment is anticipated to be the fastest growing segment in this industry, with annualized rate (CAGR) of 24% during the forecast period, in the digital biomarkers market.

Based on the Key Geographical Regions, the market is segmented North America, Europe, Asia-Pacific, Middle East and North Africa, and Rest of the World

  • North America dominated the digital biomarkers market and accounted for the largest revenue share of close to 45% in 2024.
  • In Asia Pacific, the digital biomarkers market is anticipated to demonstrate considerable growth during the forecast period.

Key Digital Biomarker Companies Profiled

The digital biomarkers market report also includes profiles of key players (listed below) that offer digital biomarker solutions:

  • Acculi Labs
  • ActiGraph
  • AliveCor
  • ATCOR
  • BACtrack
  • Biogen
  • BioSerenity
  • BioSensics
  • Eyenuk
  • Empatica
  • Feel Therapeutics
  • icometrix
  • iMediSync
  • IXICO
  • Kinsa
  • Koneksa Health
  • Kontigo Care
  • Progentec Diagnostics
  • Quibim
  • Vocalis Health

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/digital-biomarkers-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry